| Serial Number | 98263876 |
| Word Mark | REJUVE THERAPEUTICS, INC. |
| Filing Date | Thursday, November 9, 2023 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, September 17, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, September 17, 2024 |
| Goods and Services | Pharmaceutical and biological preparations for respiratory diseases and disorders; Pharmaceutical and biological preparations for use in pulmonology, immunology, oncology, infectious diseases, and degenerative diseases; Pharmaceutical and biological preparations for preventing, diagnosing, treating and managing COPD, chronic bronchitis, mucus hypersecretion, emphysema, asthma, sleep apnea, pulmonary hypertension, idiopathic pulmonary fibrosis (IPF), and other diseases, disorders, and conditions affecting the lungs and airways; Pharmaceutical and biological preparations for preventing, diagnosing, treating and managing cancer, fibrotic diseases, NASH, Crohn's Disease, osteoarthritis, viral infections, and hepatitis C; Pharmaceutical and biological preparations for improving air flow obstruction, reduce neutrophils and secreted elastase, improve mucociliary clearance, increase lung cell viability, increase alveolar regeneration, reduce smooth muscle proliferation, regulate cartilage destruction, reduce inflammation; Therapeutic agents in the nature of nebulized peptides, monoclonal antibodies, and recombinant protein domains for reversing underlying mechanisms of COPD |
| NOT AVAILABLE | "THERAPEUTICS, INC." |
| Goods and Services | Research and development in the fields of pharmaceuticals, biologics, and therapeutic treatments in the fields of pulmonology, immunology, oncology, infectious diseases, and degenerative diseases; Providing medical scientific research information in the fields of pharmaceuticals, biologics, and therapeutic treatments in the fields of pulmonology, immunology, oncology, infectious diseases, and degenerative diseases |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, December 12, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, December 12, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Rejuve Therapeutics, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Houston, TX 770028121 |
| Party Name | Rejuve Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Houston, TX 770028121 |
| Event Date | Event Description |
| Monday, November 13, 2023 | NEW APPLICATION ENTERED |
| Tuesday, December 12, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, June 18, 2024 | ASSIGNED TO EXAMINER |
| Tuesday, June 25, 2024 | NON-FINAL ACTION E-MAILED |
| Tuesday, June 25, 2024 | NON-FINAL ACTION WRITTEN |
| Tuesday, June 25, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, June 28, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, June 28, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, June 28, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, August 8, 2024 | FINAL REFUSAL E-MAILED |
| Thursday, August 8, 2024 | FINAL REFUSAL WRITTEN |
| Thursday, August 8, 2024 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Tuesday, August 13, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, August 13, 2024 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, August 13, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, August 13, 2024 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, August 13, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, August 13, 2024 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, August 13, 2024 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Wednesday, August 14, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, August 28, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, September 17, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, September 17, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |